Cargando…
Consistency of Product Quality for SB5, an Adalimumab Biosimilar
BACKGROUND: Biologics, regardless of whether they are biosimilars or reference products, are inherently variable due to their size, complexity, and the manufacturing process involved to produce them. Since a drift or evolution of quality attributes of a biologic may impact its clinical safety or eff...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971099/ https://www.ncbi.nlm.nih.gov/pubmed/36719640 http://dx.doi.org/10.1007/s40259-023-00581-x |